ArticleFrontiers in cardiovascular medicine2026
A case of progressive giant coronary aneurysm following first-generation drug-eluting stent implantation for chronic total occlusion-a case report and literature review.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary artery aneurysm (CAA) is a segmental dilation of the coronary artery and a rare condition. The incidence of CAA after drug-eluting stent (DES) implantation is 0.2%-2.3%, with giant coronary artery aneurysm (GCAA) being even rarer, occurring in approximately 0.02% of cases. We report a case of a 46-year-old female who presented with paroxysmal precordial pain in 2010. Coronary angiography was performed, and four sirolimus-eluting stents (FireBird) were implanted. Over the following decade, she experienced multiple acute coronary ischemic events. Repeat angiography revealed that coronary aneurysms had developed at all original stent implantation sites and were progressively enlarging. The patient ultimately underwent surgical treatment and recovered well during one year of follow-up. This rare case of stent-related GCAA suggests that treatment decisions should comprehensively evaluate the patient's specific conditions, including the recurrence of thrombotic events, the efficacy and safety of antithrombotic therapy, as well as the location and size of the aneurysm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.